InsiderTrades

Form 4 for HALO HALOZYME THERAPEUTICS, INC.

Accepted 2024-02-16 00:00:00 ET · period of report 2024-02-15 · accession 0001415889-24-004183 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-02-16 2024-02-15 HALO Torley Helen Pres AND CEO, Dir A - Grant $0.00 +32.8K 676.8K +5% $0
DM 2024-02-16 2024-02-15 HALO Torley Helen Pres AND CEO, Dir F - Tax $35.91 -24.7K 644.1K -4% -$885.4K
D 2024-02-16 2024-02-15 HALO Torley Helen Pres AND CEO, Dir M - OptEx $0.00 +13.1K 651.1K +2% $0
D 2024-02-16 2024-02-15 HALO Torley Helen Pres AND CEO, Dir M - OptEx $0.00 -13.1K 13.1K -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-02-15 A A 32,781 $0.00 676,841 D — — (F2) This transaction represents the vesting and settlement of performance stock units in shares of common stock of the issuer.
2 Common Common Stock 2024-02-15 F D 17,619 $35.91 659,222 D — — (F3) The reported disposition of 17,619 shares represents the shares that were withheld by the issuer as payment for minimum statutory tax withholding obligations.
3 Common Common Stock 2024-02-15 M A 13,092 $0.00 651,096 D — —
4 Common Common Stock 2024-02-15 F D 7,036 $35.91 644,060 D — — (F1) The reported disposition of 7,036 shares represents the shares that were withheld by the issuer as payment for minimum statutory tax withholding obligations.
5 Derivative Restricted Stock Units 2024-02-15 M D 13,092 $0.00 13,092 D $0.00 · — to — 13,092 Common Stock (F4) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.